Nykode Therapeutics Stock
Stocks
NYKD
NO0010714785
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.150 NOK | +2.11% |
|
-3.08% | +30.60% |
| 05-27 | Nykode Therapeutics AS Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-27 | Nykode Therapeutics AS, Q1 2026 Earnings Call, May 27, 2026 |
| Market Cap | 1.03B 108M 93.46M 86.04M 80.63M 150M 10.29B 153M 1.02B 397M 5.01B 406M 397M 17.3B | P/E Ratio 2026 * |
-4.87x | P/E Ratio 2027 * | -34.1x |
|---|---|---|---|---|---|
| Enterprise Value | 544M 57.17M 49.38M 45.47M 42.6M 79.35M 5.44B 81.05M 539M 210M 2.64B 215M 210M 9.14B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 2.79x |
| Free-Float |
56.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Nykode Therapeutics
| 1 day | +2.11% | ||
| 1 week | -3.08% | ||
| Current month | +0.48% | ||
| 1 month | -0.32% | ||
| 3 months | +0.32% | ||
| 6 months | +27.74% | ||
| Current year | +30.60% |
| 1 week | 3.06 |  | 3.25 |
| 1 month | 2.97 | | 3.6 |
| Current year | 2.21 | | 4.1 |
| 1 year | 1.44 | | 4.1 |
| 3 years | 1.44 | | 30.86 |
| 5 years | 1.44 | | 88.9 |
| 10 years | 1.44 | | 93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Engsig
CEO | Chief Executive Officer | 54 | 2018-12-31 |
| President | 49 | 2016-12-31 | |
Harald Gurvin
DFI | Director of Finance/CFO | 51 | 2021-05-02 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | - | |
Trygve Lauvdal
BRD | Director/Board Member | 57 | - |
Susanne Stuffers
CHM | Chairman | 45 | 2025-04-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-03-26 | Buy | Company | 3,000,000 | 0.9187% | ||
| 24-12-19 | Sell | Director | 100,000 | 0.0306% | ||
| 24-12-19 | Buy | Director | 100,000 | 0.0306% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.11% | -3.08% | +62.87% | -89.57% | 108M | |
| +1.03% | +2.30% | +54.92% | +111.78% | 56.42B | |
| +2.72% | +3.26% | +47.26% | +47.26% | 44.54B | |
| +1.12% | +2.79% | -13.71% | -17.53% | 22.9B | |
| +1.17% | +3.85% | +1.00% | +401.79% | 21.21B | |
| +3.81% | -5.07% | +12.00% | -29.52% | 16.4B | |
| +0.15% | +2.24% | +9.10% | -40.04% | 15.4B | |
| -0.69% | +0.82% | +27.17% | +178.31% | 13.35B | |
| +5.27% | +5.54% | +14.25% | - | 12.36B | |
| +1.61% | +1.28% | +92.88% | +215.31% | 11.15B | |
| Average | +1.83% | +1.57% | +30.78% | +86.42% | 21.38B | |
| Weighted average by Cap. | +1.72% | +2.36% | +31.94% | +100.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 162M 17.01M 14.69M 13.53M 12.67M 23.61M 1.62B 24.11M 160M 62.41M 787M 63.83M 62.47M 2.72B |
| Net income | -208M -21.87M -18.89M -17.39M -16.3M -30.35M -2.08B -31M -206M -80.24M -1.01B -82.06M -80.31M -3.5B | -41.58M -4.37M -3.78M -3.48M -3.26M -6.07M -416M -6.2M -41.22M -16.05M -202M -16.41M -16.06M -700M |
| Net Debt | -485M -51.02M -44.07M -40.58M -38.02M -70.82M -4.85B -72.34M -481M -187M -2.36B -191M -187M -8.16B | -578M -60.74M -52.47M -48.31M -45.27M -84.32M -5.78B -86.12M -573M -223M -2.81B -228M -223M -9.72B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 3.150 kr | +2.11% | 204,446 |
| 26-06-11 | 3.085 kr | +0.82% | 374,674 |
| 26-06-10 | 3.060 kr | -3.16% | 618,871 |
| 26-06-09 | 3.160 kr | -0.47% | 447,431 |
| 26-06-08 | 3.175 kr | -2.31% | 349,368 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NYKD Stock
Select your edition
All financial news and data tailored to specific country editions
